Differential (Click to cross reference) advances in neurology adverse drug reaction alemtuzumab autoimmune disease cerebral venous thrombosis cerebral venous thrombosis, deep cerebrovascular accident Clinical Pathologic Conference(C.P.C.) complications corpus callosum corpus callosum, infarction of genu of corpus callosum Guillain Barre syndrome hemorrhagic diathesis iatrogenic neurologic disorders idiopathic thrombocytopenic purpura immunomodulation interferon interferon beta 1-a intraneural hemorrhage median neuropathy middle cerebral artery, occlusion of monoclonal antibodies mononeuropathy mononeuropathy multiplex MRI, false negative MRI, venography multiple sclerosis multiple sclerosis, relapsing multiple sclerosis, treatment of peripheral nerve, lesion of plasmapheresis plasmapheresis, complications of rash splenium of corpus callosum staphylococcal protein A column therapy superior sagittal sinus thrombosis T cell lymphocytes thrombocytopenia treatment of neurologic disorder ulnar neuropathy vasculitides

Showing articles 0 to 5 of 5 Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis NEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008 Cerebral Venous Thrombosis After Immune Thrombocytopenic Purpura and Anti-D Immune Globulin Therapy J Child Neurol 23:325-330, Kayyali,H.,et al, 2008 Clinicopath Conf Leucocytoclastic Vasculitis, Due to Staphylococcal Protein A Column Therapy with CVA, Case 35-1994,, EJM1:792-800,1994., 1994 Mononeuropathy Multiplex Complicating Idiopathic Thrombocytopenic Purpura Neurol 41:1517-1518, Greenberg,M.K.&Sonoda,T., 1991 Acute Idiopathic Polyneuritis & Idiopathic Thrombocytopenic Purpura JAMA 243:256-257, Gross,P.T., 1980 Showing articles 0 to 5 of 5